Automated HIV-1 Viral Load Testing via Dried Blood Spots
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional HIV-1 viral load testing from plasma imposes restrictive requirements for sample collection, handling, and shipment, limiting the expansion of viral load testing in resource-limited settings, and existing DBS assays are costly and inefficient due to manual handling and contamination risks.
Innovation Solution
A novel automated method for detecting HIV-1 nucleic acids using dried blood spots, which includes an elution/reaction buffer system, automated sample preparation, and PCR instruments, allowing for efficient and accurate quantification of HIV-1 RNA and pro-viral DNA without the need for additional reagents or equipment, and enabling DNase treatment without additional time or inconvenience.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional plasma-based HIV-1 viral load testing is used, then measurement precision is maintained, but sample collection and handling requirements become restrictive and complex
Solution Approach 1:
The invention extracts the viral RNA from the complex plasma matrix and concentrates it onto a dried blood spot matrix, which can then be easily handled and shipped without special requirements. This extraction and matrix transformation resolves the contradiction by maintaining measurement precision while eliminating restrictive sample handling requirements.
Solution Approach 2:
The invention changes the physical state and matrix parameters of the sample from liquid plasma to dried blood spot format. This parameter change allows the sample to be stable at room temperature and eliminates the need for cold chain storage and complex handling procedures while preserving viral RNA for accurate quantification.
2Device complexity
If manual DBS assay procedures are used, then device complexity is reduced, but productivity decreases and contamination risk increases
Solution Approach 1:
The invention merges multiple manual steps (elution, extraction, purification, and setup of PCR reactions) into a single automated workflow using the m2000sp system. This integration maintains procedural simplicity from the user perspective while dramatically increasing productivity through automation.
Solution Approach 2:
The invention replaces manual mechanical operations (pipetting, transferring, mixing) with an automated robotic system that performs these functions programmatically. This substitution eliminates human error and contamination risks while increasing throughput capacity.
3Measurement precision
If DNase treatment is added to DBS assays, then measurement precision improves by reducing DNA interference, but loss of time and additional reagent handling increase
Solution Approach 1:
The invention incorporates DNase treatment as a preliminary step within the automated workflow, performing DNA degradation before RNA extraction and PCR setup. This preliminary action ensures that DNA interference is eliminated early, maintaining measurement precision without adding perceived time to the overall assay process.
Solution Approach 2:
The invention maintains continuous automated processing throughout the DNase treatment step, where the robotic system automatically adds reagents, incubates samples, and proceeds to the next step without manual intervention. This continuity eliminates idle time and keeps the workflow moving efficiently.
4Productivity
If automated sample preparation is implemented, then productivity increases and measurement precision improves, but device complexity increases
Solution Approach 1:
The invention uses the m2000sp system to perform multiple functions (sample elution, nucleic acid extraction, purification, and preparation of PCR reactions) within a single automated platform. This multi-functionality increases productivity and precision while consolidating device complexity into one integrated system rather than multiple separate devices.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly reduces errors and contamination, increases accuracy and efficiency, and improves sensitivity, enabling the use of DNase without additional buffers or heating, thus enhancing the usability and sensitivity of HIV-1 viral load testing in resource-limited settings.
Implementation Method 1
eluting the blood sample from the solid carrier with the elution buffer to create an eluted sample
Implementation Method 2
eluting the blood sample from the solid carrier
Implementation Method 3
DNase treatment is desired or required in the prior art assays
Implementation Method 4
DNase effectively degrades DNA within the time period of 30 minutes
Implementation Method 5
performing PCR on the extracted nucleic acids in the processed sample with the automated, programmable PCR instrument
Implementation Method 6
performing PCR on the extracted nucleic acids
Data Source
Figure 1a~1c
Figure 2a~2c
Figure 3a~3c
AI summary
The present invention provides novel and non-obvious improvements to dried blood spot testing for HIV-1 viral load useful for diagnosis and monitoring treatment progression.